THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for...
The Supply Veins Co-Founder and CEO is a PenFed Foundation for Military Heroes Veteran Entrepreneur Program Alumnus
Multimedia: VIDEO LINK
MIAMI, Aug. 1, 2025 /PRNewswire/ -- Autoket,...
Presentations to include efficacy, safety and opioid use reduction data in two different surgery models as well as pharmacokinetics data
PITTSBURGH, Aug. 1, 2025 /PRNewswire/...
New Orders and Backlogs Contracting; Production Growing and Employment Contracting; Supplier Deliveries Faster; Raw Materials Inventories Contracting; Customers' Inventories Too Low; Prices Increasing; Exports...
Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs
Respective Generics Businesses and Endo's Sterile Injectables Business to be Combined and Spun...
LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces a Standby Equity Purchase Agreement (SEPA) for up to $30 million worth of common stock over the course of 36 months.